Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Decitabine × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 24 Myelodysplastic Syndromes 13 Leukemia, Myelomonocytic, Chronic 7 Leukemia 5 Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Monocytic, Acute 2 Thrombocythemia, Essential 1 Systemic Mastocytosis With an Associated Hematologic Neoplasm 1 Solid Tumor 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms 1 Myeloid Malignancies 1 Lymphodepleting Chemotherapy 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia, Basophilic, Acute 1 Human Papillomavirus-Negative Neck Squamous Cell Carcinoma 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Anemia, Refractory 1 Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

Cyclophosphamide 6 fludarabine 5 Mycophenolic Acid 5 Azacitidine 5 Whole-Body Irradiation 4 Tacrolimus 4 venetoclax 3 fludarabine phosphate 3 decitabine and cedazuridine drug combination 2 Vorinostat 2 Specimen Handling 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Busulfan 2 Biopsy 2 sulforaphane 1 ruxolitinib 1 enasidenib 1 cedazuridine 1 Triamcinolone 1 TAK-243 1 Stem Cell Transplantation 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Filgrastim 1 Cyclosporins 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡